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Abstract
Prostate cancer is the second most common cancer in men and one of the
leading causes of cancer deaths among men in America. Interestingly, it has been
shown that immigration and the adaption of a Western-Diet can significantly increase the
risk of prostate cancer development in men, suggesting diet may play a key role in
prostate cancer development.
Advanced glycation end products (AGEs) are reactive metabolites that are
produced during normal metabolism and accumulate in our tissues and organs as we
get older. AGE content in the Western-Diet has significantly increased over the years
leading to an increase of AGE consumption through the foods we eat, thus leading to an
accumulation in our tissue and organs. The accumulation of AGEs can lead to
pathogenic effects such as oxidative stress, inflammation, known factors which can
contribute to the development and progression of prostate cancer.
This study examines the effects of a high AGE diet on prostate tumor growth in a
syngeneic mouse model. Mice were fed a constant control (regular) diet, a constant high
AGE diet, a diet switched from regular to high AGE, or a diet switched from high AGE to
regular. Each mouse group was fed their respective diet from weaning (3 weeks),
followed by injection of MYC-CaP cells into the flank at 6 weeks of age, and monitored
until 12 weeks of age. Diet switch groups were switched at point of injection to the
opposite diet. From point of injection, tumor growth was measured. At the experimental
endpoint, tumors were excised and analyzed through immunofluorescence (IF),
hematoxylin and eosin (H&E) staining, RNA sequencing, and Real Time PCR analysis.
The high AGE diet revealed a threefold increase in tumor volume when compared to the
regular diet, however when diet was switched tumor growth was not fully inhibited.
Histology revealed changes in the morphology of the tumors from regular to high AGE
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diets showing an increase in cell density. RNA sequencing along with Real Time PCR
showed genes and pathways associated with prostate cancer development to be altered
by a high AGE diet to promote cancer development.
In summary, we observed a significant change in the cellular and molecular
components of the prostate tumors when exposed to a diet high in AGEs, possibly
leading to the link between diet and increased prostate cancer development.
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Introduction/Background
Advanced Glycation End Products
Advanced Glycation End Products (AGEs) are reactive metabolites found
endogenously in the tissues and organs which irreversibly accumulate as we grow older.
AGEs are formed through the Maillard Reaction during normal metabolism1. This
reaction, shown in Figure 1, occurs when sugar attaches to amino acids on protein, lipid,
or DNA to form the Schiff Base. The Schiff base then goes through chemical
rearrangements to form Amadori products or the glycation product. Both can then
undergo further rearrangements such as oxidations, reductions, and hydrations to form
AGEs. Each stage of the Maillard Reaction is reversible until the Amadori product
undergoes the chemical rearrangements to form AGEs1-3.

Figure 1: AGE Formation. The classic pathway of endogenous AGE formation is through
the Maillard Reaction when glucose forms the Schiff base although AGEs can be formed
through Glucose autoxidation and Lipid peroxidation. Taken from “Dietary Advanced
Glycation End Products and Aging” by C. Luevano-Contreras and K. ChapmanNovakofski, 2010, Nutrients, 2(12):1247-1265.
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The proteins that are altered by glycation are resistant to degradation and leads
to an accumulation of AGEs in the tissues and organs4,5. Glucose autoxidation and Lipid
peroxidation can lead to -oxaldehydes or AGE precursors which also lead to the
formation of AGEs (Figure 1)1,6. Accumulation of AGEs can have pathogenic effects
which may be caused by the increase in oxidative stress, inflammation, and crosslinking
of proteins, all of which can alter cell structure and function.
Dietary derived AGEs

AGEs are found exogenously in foods and the level of AGEs can increase
depending on the manner in which they are cooked or prepared. Food preparation using
high dry heat such as grilling, broiling, roasting and frying accelerates AGE formation2,7.
The Maillard Reaction occurs in foods due to the high heat of the cooking process and
creates the browning/charred color. Lean red meats and poultry can contain higher
levels of AGEs do to highly reactive amino-lipids within muscle along with reduction of
sugars which occur during the cooking process6,8. While cooking food products can
directly increase the production of AGEs, glycation-oxidation reactions can occur at cool
temperatures, albeit at a slower rate, leading to more accumulations of dietary AGEs.
Studies have shown that dietary AGEs are absorbed and greatly contribute to the body’s
AGE pool. Highly processed foods are also high in AGEs due to the preservation
methods used to prepare them and the fact that they are added to processed foods to
improve taste and appearance. 1,2,7,9,10.

AGEs and Chronic Disease
Accumulation of AGEs is linked to many chronic diseases including the four “big
killers” of cardiovascular disease, diabetes, Alzheimer’s, and cancer. AGEs irreversibly
accumulate in our tissues and organs and contribute to organ failure and dysfunction2,7.
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They can also contribute to chronic disease phenotypes by causing protein dysfunction
through the formation of intra-crosslinking and inter-crosslinking11. Wrinkles in the skin
are an example of AGE crosslinking of collagen fibers.

High AGE diets have been connected to higher AGE levels in conditions such as
atherosclerosis and kidney disease. In cardiovascular disease, accumulations of AGEs
cause plaque formation and arterial stiffness. Restriction of dietary AGEs in foods has
been shown to help delay chronic diseases and aging in animals12. Due to the increase
in sugar levels, people with diabetes generate more endogenous AGEs than those
without diabetes13,14. The buildup of AGEs can be critical for those with renal disease
because they have impaired renal function, which is the only inefficient way AGEs can
be cleared from the body.13. While high AGE diets can increase the effects of chronic
illnesses, AGEs can also lead to the progression of aging which can be seen in the
onset of cataracts1,15. Aging is not observed as a disease, but it leads to the
development of these diseases and is associated with higher accumulations of AGEs.

Receptor for Advanced Glycation End Products
The Receptor for Advanced Glycation End Products (RAGE) is a transmembrane
immune receptor16. RAGE leads to the activation of master transcriptional regulators
such as nuclear factor kappa-light-chain-enhancer of activated B cells (NF), signal
transducer and activator of transcription 3 (STAT3), and Hypoxia-inducible factor 1-alpha
(Hif1) which in turn alters immune profiles through altered expression of cytokines,
chemokines, and adhesion molecules (Figure 2)17. RAGE normally functions as a
pattern recognition receptor in response to danger signals such as infection. RAGE, like
other receptors, has different isoforms. The oncogenic full-length receptor can undergo
alternative splicing while the tumor suppressive soluble RAGE (sRAGE) can be formed
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through splicing and membrane associated proteases18-21. sRAGE can cancel the effects
of AGEs22. This form of RAGE can prevent full length RAGE from binding to ligands.
While the full length receptor activates transcription factors such as NF and
inflammatory molecules, sRAGE can bind to monocytes and assist in the differentiation
into macrophages20.

AGEs function as a ligand for RAGE which is overexpressed in multiple human
cancers including prostate cancer19,23. The cellular effects of AGEs can be exerted when
they bind to RAGE on the surface of a cell. AGEs bind to RAGE which activates
downstream signaling pathways such as phosphatidylinositol-3-kinase (PI3K) and
mitogen activated protein kinase (MAPK) as shown in Figure 2. These signaling
pathways lead to the translocation of NF to the nucleus which in turn the activation of
these transcription regulators activates genes for cytokines, growth factors, and
adhesion molecules such as Tumor Necrosis Factor-alpha (TNFa), interleukin 6 (IL-6),
and vascular cell adhesion molecule 1 (VCAM-1) 3,17,23,24. RAGE activation is linked to an
increase in immune cell recruitment as well as proliferation, survival, migration, and
invasion of tumor cells3,16,19.
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Figure 2: AGE:RAGE Signaling. Exogenous and endogenous AGEs accumulate in the
tissues and bind to RAGE. PI3K and MAPK pathways are activated causing downstream
translocation of NF. An increase in transcription and inflammatory markers leads to a proinflammatory and pro-oxidant microenvironment.

An increase in cell signaling through RAGE can be a result of endogenous AGEs
as well as high intake of AGEs through diet. AGE:RAGE signaling has been shown to
cause immune mediated chronic inflammation, a trigger associated with most chronic
diseases including diabetes, Alzheimer’s and cancer11.

The Prostate & Prostate Cancer

The prostate is an accessory gland for the male reproductive system which is
responsible for producing and secreting fluids to assist in male ejaculate. This fluid is
significant for male fertility. The prostate is only found in mammals and is a small organ
located below the bladder surrounding the urethra25,26. The prostate contains many
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different cells types such as epithelial cells expressing cytokeratin, basal cells, luminal
cells, neuroendocrine cells, and fibroblasts secreting extracellular matrix and
glycoproteins25-27.

The human prostate first grows in five pairs of epithelial buds which form lobes
but in the adult form, the gland becomes a single lobe divided into zones. This structure
contains the central, transition, and peripheral zones25,28. Unlike humans, rodent
prostates have four distinct pairs of lobes; the anterior, ventral, lateral, and dorsal
(Figure 3). Each of the five lobe types contains different branching patterns. The dorsal
and lateral lobes contain large similarities to the human prostate. Although different in
size, human and rodent prostate epithelium contains luminal, basal, and neuroendocrine
cell populations (Figure 4)25-27.

Figure 3: Adult Mouse Prostate. The four pairs of lobes of the
mouse prostate, the ventral, lateral, dorsal, and anterior surround the
urethra just under the bladder. Taken from “Prostate Organogenesis:
tissue induction, hormonal regulation and cell type specification” by
R. Toivanen and M. Shen, 2017, Development; 144(8): 1382-1398.
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Figure 4: Key Cells in Prostate Cancer Microenvironment. Many innate cells have
been found in the prostate stroma to participate in the development and progression of
cancer and the potential to promote cell growth. Taken from “Prostate Organogenesis:
tissue induction, hormonal regulation and cell type specification” by R. Toivanen and M.
Shen, 2017, Development; 144(8): 1382-1398.

Prostate cancer begins as benign prostatic epithelial cell transition to prostatic
intraepithelial neoplasia (PIN) which then forms localized prostate cancer, and eventually
advanced adenocarcinoma in metastatic prostate cancer28-30. Donald Gleason created a
grading system for prostate adenocarcinomas called the Gleason grading system which
scores prostate cancer based on aggressiveness observed in histological patterns27,28,30.

In prostate cancer, complex changes occur in the cells of the microenvironment
such as transformation in the stroma and connective tissue, remodeling of the
extracellular matrices (ECM), and signals sent to the immune system recruiting
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inflammatory cells during tumor growth28,30. Dendritic cells and macrophages of the
innate immune system cause cancer associated inflammation4,15,27. Chronic
inflammation is greatly associated with the development of prostate cancer. Carcinoma
associate fibroblasts (CAFs) are reactive stroma found beginning in the PIN stage of
prostate cancer and in greater quantities with prostate cancer progression28,29,31. CAFs
secrete ECMs which are associate with genetically altering prostate epithelial cells,
enhancing proliferation, and invasiveness. The interaction between CAFs and prostate
cancer is greatly mediated by androgen receptor (AR) which coordinates cell adhesion
between the stroma and tumor. AR is a master regulator for growth and differentiation
which transfers signaling through ECM to regulate cancer cell behavior in the
microenvironment28,29,31.

Malignant cancer cells have been shown to recruit non-tumorigenic cells and
causing these cells to promote metastatic properties31. The cancer cells have the ability
to transform dormant bystander epithelial cells which resulted in those cells expressing
elevated EMT, stem cell, and neuroendocrine through activation of cMYC/MAX and
other receptor signaling28,31. MYC is an oncogene involved in a network responsible for
cell growth, differentiation, and apoptosis. This transcription factor network, MYC-MAX
being one part of it, relies on protein to protein interactions for functioning31. MYC-MAX
acts as a molecular switch to activate promoter regions. MYC has been found to be upregulated in prostate cancer tissues and may be the cause of initial PIN31-33. The MYCMAX network is completed by the MAX-MAD1 portion which acts as the repressor. MYC
and MAD1 also known as MXD1 are transcription factors which act as opposing forces
on a gene34. The MYC-MAX side of the network works to activate many promoters using
histone acetyltransferases while the MAX-MAD1 competes to repress the promoters
using histone deacetylases (Figure 5)34,35.
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Figure 5: MYC-MAD-MAX Regulatory Network. Gene activation and
repression through MYC-MAD-MAX.

Among men, prostate cancer is the second most common cancer in the world
and fifth most common cause of death. Second to skin cancer, prostate malignancies
are one of the most frequent cancers in men29,36,37. Localized prostate cancer can have
high chances of survival while metastatic prostate cancer is generally incurable. One in
seven men will be diagnosed with prostate cancer in their lifetime27,30,. Age is a major
risk factor along with family history of breast and prostate cancers. If there is a family
history of the disease, there is a ten times higher chance of developing prostate
cancer37. When compared to other populations, African American men had an increased
risk of the disease. High fat diets can also contribute to the disease27,30,37,38.

Diet and Prostate Cancer

Many lifestyle factors shown to have a significant effect on cancer development
are high body mass index, high consumption of high carcinogenic dietary factors and low
consumptions of vegetables6,9,12. Cancer cells generate ATP through the Warburg Effect,
commonly known as aerobic glycolysis when they consume glucose and produce lactic
acid39,40. When a person is consuming a diet high in high sugar, highly processed foods,
the tumor cells are provided with everything they need to grow. Dietary factors can also
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lead to increase inflammation within the prostate. Consumption of high carcinogenic
dietary factors is also thought to be a cause of multiple cancers including prostate
cancer38. These diets include a high consumption of red and processed meat, foods high
in saturated fats, and the low consumption of fruits and vegetables. A high meat intake
and the consumption of well cooked meat are independently associated with a greater
risk of prostate cancer6,8,37,38. Similarly, an increased risk of colon cancer is related to
heterocyclic amines (HCA) and polycyclic aromatic hydrocarbons (PAH) which are
generated in red and processed meat through cooking at high temperatures on an open
flame or by frying or grilling foods6. HCAs and PAHs have also been shown to cause
damage in prostate tissue. These molecules are compounds formed through incomplete
combustion and can be found in soil, water, and food. They can be inhaled or ingested
both of which have the ability to lead to DNA mutations6,41. Processed meat contains
nitrites and nitrates which are associated with a high risk of advanced prostate cancer.
While high consumptions of red meat are associated with harmful effects, high
consumptions of fish have shown a reduction of mortality from prostate cancer6,8,38.

As it may seem as though all foods are the enemy, there are options of food
preparation that can slow down AGE formation and fight inflammation. Foods such as
olive oil are beneficial because they contain content such as oleic acid and phenolic
antioxidants6. Foods high in antioxidants contain preventative effects against prostate
cancer. Oleic acid is less susceptible to oxidation and phenolic antioxidants protect
against lipid peroxidation which can form AGE precursors6. It has been shown that
phenolic compounds can have chemo-preventative effects on cancer cell signaling and
cell cycle progression. Soy and green tea have anti-inflammatory properties which have
been shown to decrease cancer risk6.
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AGEs and Prostate Cancer

Higher levels of AGEs are associated with an increased risk of prostate cancer
and the receptor for AGEs is elevated in prostate tumor tissues. It has been shown in
previous studies that AGE exposure induces prostate cancer cell proliferation and RAGE
is overexpressed in prostate cancer11,24. AGE:RAGE signaling has been observed in the
development, proliferation, and metastasis of tumors. It has been shown that higher
expression of RAGE can lead to progression of cancers while blocking of RAGE can
suppress tumor growth and metastases. This pathway promotes cancer processes such
as ECM remodeling, angiogenesis, and metastasis11,24. AGEs have the potential to alter
cell signaling pathways in order to promote these processes. RAGE expression has
been observed to be associated with prostate cancer progression and poor patient
outcome. Prostate cancer tumor cells contain uncontrolled growth properties after
undergoing molecular alterations.
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Non-Cancer

Cancer

Epithelial Cells

Figure 6: AGE levels in Prostate Cancer Patients. IF staining levels in non-cancer and prostate
tumor tissue (Gleason 7) showing an increase in AGE, RAGE, and pNF levels of the tumor
tissue. The image on the right shows the IF staining of AGE levels in the tumor tissue is
increased mainly in epithelial cells.

In our published studies, the AGE levels in non-cancer and prostate cancer
patients were examined and a correlation between race and tumor accumulation were
identified. Immunofluorescence (IF) staining showed AGE, and its downstream effectors
RAGE, and activated NF (pNF) were elevated in prostate cancer tissue with the
highest accumulation seen in African American men and in more aggressive tumors
(Figure 6). Cells treated with AGE also exhibited AGE stimulation of cell growth and
migration are dependent upon AGE. The Gleason scale is used to evaluate prostate
cancer based on low numbers establishing a less aggressive cancer while higher scores
are poorly differentiated and more aggressive. Prostate cancer patients with high grade,
Gleason scale 7-9, were shown to have greater circulatory AGE levels than those with
low grade, Gleason 4-6 tumors through ELISA analysis Further immunofluorescence
staining showed, AGE levels to be highest in the tumor epithelial cells11.
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Research Plan

Overall Rationale: The overall goal of this project was to test the hypothesis that
chronic AGE consumption can increase the progression of prostate tumor growth. We
wanted to observe tumor growth in mice fed either a regular or high AGE diet and in
mice where the diets were swopped at the time of tumor cell injection. Our data strongly
supports the hypothesis that dietary AGEs promote prostate tumor growth by stimulating
the AGE-RAGE signaling pathway. This is based upon the premise that 1) AGE levels
are higher in tumor tissue than in non-cancer tissues, 2) Prostate cancer patients have
elevated levels of RAGE, and 3) AGE accumulation is increased by exogenous intake of
an unhealthy diet. The proposed studies will go beyond our foundational studies. They
will uncover in vivo mechanisms by which chronic exposure of AGEs may promote
prostate carcinogenesis, define if diet-change can inhibit growth of AGE induced tumors,
and define the genes differentially expressed by a high AGE diet.

Hypothesis: Dietary AGEs promote prostate tumor growth by stimulating the AGERAGE signaling pathway.

Specific Aim 1: To test the working hypothesis that chronic AGE consumption
promotes prostate tumor growth.

Rationale: Endogenous AGE production through glycolysis and oxidative stress along
with a high intake through food consumption can lead to greater AGE accumulation in
the body. AGE accumulation contributes to chronic disease but the relationship between
prostate cancer and AGEs are unclear. While AGEs have been shown to impact cancer
associated pathways in vitro, their potential to promote tumor growth in vivo has not
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been assessed. Thus, we will test the working hypothesis in a mouse syngeneic prostate
cancer model fed regular (Reg) and high AGE diet.

Task 1: Establish mouse model for Reg/High AGE diets
Task 2: Assess the effects of a high AGE diet on Tumor growth
Task 3: Evaluate RAGE levels in excised tumors from specified diets
Task 4: Evaluate morphological differences in tumor structures among diets
Experimental Design

Development of Dietary Mouse Model and Tumor Development. We used a MYCCaP syngeneic mouse model fed specific dietary regimens to define the effects of
chronic AGE consumption on prostate tumor growth. Mice were divided into two groups
and fed the following diets: 1) controls fed with standard mouse diet and 2) high AGE
group (TestDiet 58G7 autoclaved at 120°C for 15 min). Male FVB/n mice were weaned
at 3 weeks of age and tagged for identification. AGE specific diets were started at
weaning and food consumption was monitored and resupplied each week. Wildtype
MYC-CaP mouse prostate cancer cells were grown in culture. After 3 weeks on each
respective diet, 0.5x106 MYC-CaP cells (150ul per mouse: 1:1 ratio Corning Matrigel
Growth Factor Reduced Basement Membrane Mix/cells) were subcutaneously injected
into the flanks. Injection sites were observed approximately every three days and as
tumors developed, measurements were taken using a Traceable measuring device
(Fisher Scientific) and recorded. Tumors were allowed to grow for 6 weeks before
excision. At this time, terminal blood was also collected for AGE analysis by ELISA.
Tumors were measured with a ruler, weighed using a Mettler Toledo AL54 (Columbus,
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OH) precision balance, and samples were flash frozen and paraffin embedded for future
analysis.

Paraffin Embedding. After extraction, MYC-CaP Tumors were placed into 4% PFA
overnight. Followed by a series of washes to dehydrate the tissue: 1X 70% EtOH for 1
hour, 2X 95% EtOH, 2X 100% EtOH for 1 hour each, toluene for 1-4 hours. Tumors
were then placed in a 50/50 mix of toluene and paraffin at 60°C overnight. The next day,
tumors were incubated in paraffin 2 times for 2 hours each at 60°C and finally, tumors
were embedded in paraffin.

AGE/RAGE IF. In order to analyze the levels of AGE and RAGE present in the MYCCaP tumors, the tumors were paraffin embedded and sliced 5um thick in order to be
utilized for immunofluorescent analysis. The slides were deparaffinized at 60°C for 1
hour in a glass hybridization chamber. After the deparaffinization, the tissue was rehydrated through a series of washes; 2x Xylene for 20 minutes, 3x 100% EtOH for 10
minutes, 2x 95% EtOH for 10 minutes, 1x 70% EtOH for 10 minutes, 1x 50% EtOH for
10 minutes, and 3x diH2O for 5 minutes each. For the Antigen retrieval process, unmask
epitope with citrate buffer (Vector Laboratories Antigen Unmasking Solution; Burlingame,
CA) in 1 in 10 in water. The vegetable steamer according to the manufacturer’s
instructions using H2O in the base of the steamer and preheat. Pap jar containing the
diluted unmasking solution was placed in a microwave and brought to boiling, then
placed in a preheated vegetable steamer. The slides were added to the pap jar
containing the unmasking solution and covered for 20 minutes at 90°C. When 20 min
elapsed, the vessel was removed and placed under cold tap water for 10 min. After
cooling, the slides were washed in 1x Tris Buffered Saline (TBS) 0.025% triton for 5
minutes on an orbital shaker. The circumference of the tumor tissue was marked using a
hydrophobic pen (ImmEdge, Vector Laboratories) and tissue were incubated for two
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hours with 10% normal serum with 1% Bovine Serum Albumin (BSA) in a humidified
chamber to block non-specific binding. Primary antibody was diluted in TBS with 1%
BSA and applied to the slides to incubate 4°C overnight in a humidified chamber (Table
1). The primary antibody was removed by washing the slides in 1x PBST, 3 times for 5
minutes on an orbital shaker. The slides were incubated in 0.3% H2O2 in TBS for 15 min
to remove endogenous peroxidase and then washed in 1X Phosphate Buffered Saline
(PBS) for 5 minutes. With the lights off, the fluorescent-conjugated secondary antibody
(Life Technologies Eugene, OR) diluted in 1% BSA (TBS) was added to the slides and
incubated for 1 hour at room temperature (Table). Slides were washed again in 1x PBST
3 times for 5 minutes on an orbital shaker. The Hoechst counterstain (Life Technologies,
Eugene OR) was added to the slides for 8 minutes at a 1:25000 dilution then washed
with 1X PBST 3 times for 5 minutes. Glass cover slips were then mounted on top of the
slides using Fluoro-gel with Tris buffer (Electron Microscopy Sciences, Hatfield, PA).
Imaging was completed using Olympus DP80 microscope (Olympus American, Inc.
Center Valley, PA).

Table 1: AGE/RAGE Immunofluorescence
Ab
Supplier/Part #
Primary Ab
Dilution/
Block/Incubation
Time
AGE
Abcam
2hr block 10%
Ab23722
normal horse serum
in 1% BSA,
1:200 AGE in
1%BSA overnight
RAGE
Abcam
2hr block 10%
Ab37647
normal horse serum
in 1% BSA,
1:100 RAGE in
1%BSA overnight

Secondary Ab
Dilution/
Incubation Time

Microscope/
Exposure

1:1000 Anti-Rabbit
488, in 1% BSA 1hr
at room temp

10x,
74.63ms

1:1000 Anti-Rabbit
488, in 1% BSA 1hr
at room temp

10x,
74.63ms
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ImageJ. In order to better analyze the AGE/RAGE immunofluorescence images we
used Image Processing and Analysis in Java (ImageJ, National Institute of Health)
fluorescent quantification. The images taken with the Olympus microscope were saved
as JPEG files and opened using the ImageJ software. The area on the image was
selected and the software calculated the area, average pixels, and standard deviation of
the image. The data was then inserted into an Excel spreadsheet where the averages
for all the regular diet tumor images and the high AGE diet tumors were averaged
together and statistical analysis was done to assess the significance.

H&E. In order to assess morphological changes in the MYC-CaP tumors among diets,
paraffin embedded tumor tissue was sliced 5μm thick and utilized for Hematoxylin and
Eosin staining analysis. Slides were deparaffinized at 60°C for 1 hour. Followed by a
series of washes to rehydrate the tissue: 3X xylene, 3X 100% EtOH, 1X 95% EtOH, 1X
80% EtOH each for 3 minutes and then diH20 for 5 minutes. Samples were then covered
with Hematoxylin (Fisher Scientific, Fair Lawn, NJ) for 3 minutes and rinsed in diH20.
Slides then followed a series of washes: tap water for 5 minutes, HCl-EtOH 8-12 dips, 2tap H20 for 1 minute, and diH20 for 2 minutes. Tissue was then covered by Eosin (Fisher
Scientific, Fair Lawn, NJ) for 30 seconds. Followed by another series of washes to
dehydrate the tissue: 3X 95% EtOH, 3X 100% EtOH for 5 minutes each, 3X xylene for
15 minutes each. Glass cover slips were then mounted on top of slides using
Permount® (Fisher Scientific, Fair Lawn, NJ). Imaging was completed using an Olympus
DP80 microscope (Olympus American, Inc. Center Valley, PA).
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Results.

A High AGE Diet promotes prostate tumor growth.
Visible differences in tumor development and growth were observed in the
mouse syngeneic mouse models fed the specific diets (Figure 7). Measurements were
taken every three days and at the start of palpable tumor formation. When tumors were
extracted at 24 days after cell injection, mice fed high AGE diet showed a threefold
increase in tumor volume when compared to the regular diet fed mice (Figure 8).

Regular
Diet

High AGE
Diet
Figure 7: MYC-CaP Endpoint Tumor Size. Tumors from
High AGE diet fed mice are visibly larger when compared
to the Regular diet fed mice.
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Figure 8: MYC-CaP Tumor Volume Progression. High AGE diet Tumors had a threefold
increase in tumor volume when compared to the Regular fed mice.

Differential AGE staining was observed between mice fed a high AGE and regular
diet.

Figure 9: AGE/RAGE IF staining of MYC-CaP Tumors. Images of AGE and RAGE
immunofluorescence staining (Left) of Regular and High AGE tumors. AGE staining shows an
increase in staining in localized cells of High AGE tumors while RAGE staining shows a slight
increase in overall staining. ImageJ fluorescent quantification analysis of the IF images.
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Tumor AGE IF staining in mice fed a regular diet was uniformly spread
throughout the tissue, while in the high AGE fed mice; it was localized to specific tumor
areas. Overall AGE staining was at a similar intensity but was more intense in localized
areas of signal in the high AGE fed mice. While tumor RAGE IF staining showed trend
towards higher RAGE levels in mice fed the high AGE diet when compared to regular,
this was not statistically significant (Figure 9).
High AGE tumors showed more Hematoxylin staining in the H&E slides.
Eosin stains the negatively charged or basic structures such as the cytoplasm
within the cells pink or red. Hematoxylin stains positively charged or acidic structures
such as the nucleus within the cell purple or blue. We observed a higher density of cells
in tumor slices taken from mice fed a high AGE diet compared to those fed a regular diet
(Figure 10).

1039Reg

1048High

Figure 10: Change in Morphology due to high AGE diet. H&E staining of regular and
high AGE tumors shows an increase in cell density displayed by the positive Hematoxylin
staining.

Discussion and Alternative Approaches.
In this aim, we showed for the first time that a high AGE diet leads to significantly
increased tumor growth in vivo. The mice fed a high AGE diet showed a threefold
increase in tumor volume when compared to the regular diet fed mice. Critically,
experiments in the lab have shown no differences in food consumption and weight gain
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between the high AGE and control diet fed mice during the study. Our lab has also
shown the high AGE food has increased exogenous AGE levels compared to the regular
diet.
AGEs have a long biological half-life and are resistant to degradation which
allows them to accumulate in the tissues and organs and activate the RAGE signaling
pathway. This increase in accumulation of AGEs can lead to an increase in oxidative
stress, inflammation, and eventually a feedforward loop in RAGE activation which
causes further endogenous AGE production3,23. This constant cycle of AGE production
along with increased inflammatory properties within the tumor microenvironment may
promote cell proliferation increasing the tumor volume and cell density as shown in the
H&E staining. Future experiments may assess inflammatory phenotypes and oxidative
stress levels in the experimental mice to define a potential mechanism promoting AGE
mediated effects on prostate tumor growth.
The tumor AGE IF staining in mice fed a regular diet was uniformly spread
throughout the tissue, while it was localized to specific tumor areas in the high AGE fed
mice. The overall AGE staining was at a similar intensity but was more intense in
localized areas of signal in the high AGE fed mice. The RAGE IF staining of the tumor
tissue showed a trend towards higher RAGE levels in mice fed the high AGE diet when
compared to regular but was not statistically significant. Along with the feed forward loop
of RAGE activation and AGE production within the high AGE environment, AGEs have
the ability to alter cell structure and function which could cause certain cells to become
more localized in the AGE IF1,3. Future experiments could perform co-localization
studies to define if the areas of high AGE also contain high RAGE levels.
RAGE signaling activates downstream signaling pathways which leads to the
translocation of NF and activation of genes for cytokines, growth factors, and
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adhesion molecules. RAGE activation is linked to an increase in immune cell
recruitment as well as proliferation, survival, migration, and invasion of tumor
cells3,17,23,24.As RAGE is the cognate receptor for AGE, we anticipate that RAGE levels
would correlate with high tumor AGE and increased RAGE activation would be reflected
by increased proliferation. We anticipate that loss of RAGE expression would negate
AGE induced tumor growth. We have generated FVBN RAGE-/- mice. By repeating the
dietary AGE syngeneic model with the RAGE-/- mice we can define the AGE-RAGE
dependent effects on tumor growth. A potential caveat was that AGE induced changes in
tumor growth would not be reflected by changes in RAGE. An alternative approach
would be to assess the levels of alternative but less characterized AGE receptors such
as galectin 3, CD36 and SR-A.

Specific Aim 2: To test the hypothesis that dietary-change can inhibit the growth
of AGE induced prostate tumors.

Rationale: Constant intake of AGE laden foods and inefficient removal of AGEs leads to
leads to greater accumulation. However, it is unclear if the tumor promoting effects of
AGEs are reversible through diet change. We will test the hypothesis using our AGE
dietary model wherein diets are swapped at the time of tumor cell injection.

Task 1: Assess the effects of changing the diet from a regular diet to a high AGE
diet.
Task 2: Assess the effects of changing the diet from a high AGE diet to a regular
diet.
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Experimental Design
Dietary change Mouse Model. We used the same syngeneic mouse model stated in
Aim 1. Wildtype MYC-CaP mouse prostate cancer cells were grown in culture. After 3
weeks on each respective diet, 0.5x106 MYC-CaP cells (150ul per mouse where: 1:1
ratio Matrigel/cells) were subcutaneously injected into the flanks. At time of injection, the
respective diets were changed. Mice started on standard mouse diet were switched to
the high AGE group (TestDiet 58G7 autoclaved at 120°C for 15 min) and mice started on
high AGE food were switched to standard mouse diet. The diet switch model was
compared to our continuously fed standard diet and high AGE groups in Aim 1. Injection
sites were observed approximately every three days and as tumors developed,
measurements were taken using a Traceable measuring device (Fisher Scientific) and
recorded. Tumors were allowed to grow for 6 weeks before excision. Terminal blood was
also collected for AGE analysis by ELISA. Tumors were measured with a ruler, weighed
using a Mettler Toledo AL54 (Columbus, OH) precision balance, and samples were flash
frozen and paraffin embedded for future analysis.
Results.
Switching from a regular to a high AGE diet delays AGE mediated effects of tumor
growth.
The diet switch from Regular diet to high AGE diet initially did not promote tumor
growth. However, around day 21 after injection, we saw a defined and significant
increase in AGE mediated tumor growth that was not observed in mice fed a regular diet
(Figure 11). This data indicates that the high AGE diet has immediate effects on prostate
tumor growth.
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Figure 11: Tumor volume progression of Diet Switch from regular to high AGE. Tumor
growth in Diet swap mice from regular Diet to high AGE diet. Tumor growth is delayed but
toward extraction, spikes in growth.

Switching from a high AGE diet to a regular diet only partially negates AGE
mediated tumor growth.
While the diet switch from a high AGE diet to a regular diet slowed AGE
mediated prostate cancer growth, growth was significantly greater than that observed in
the mice fed the regular diet. This data suggests that an initial AGE diet may prime the
tumor microenvironment for tumor growth even though the diets are changed towards a
regular diet (Figure 12).
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Figure 12: Tumor volume progression of Diet Switch from high AGE to regular. Tumor
growth in diet swap mice from a High AGE diet to a Regular diet. The diet swap tumors follow
consistent growth even though switch to a Regular diet.

Discussion and Alternative Approaches.
Our data indicates immediate and long lasting effects of dietary AGEs on tumor
growth. The diet swap from regular diet to high AGE diet did not promote tumor growth
initially but spiked around day 21 after injection. We saw a defined and significant
increase in AGE mediated tumor growth which was not observed in mice fed a regular
diet. This leads us to the assumption that the high AGE diet has immediate effects on
prostate tumor growth. The diet swap from a high AGE diet to a regular diet slowed AGE
mediated prostate cancer growth. While the growth was delayed, the growth was still
significantly greater than that observed in the mice fed the regular diet. We postulate that
an initial high AGE diet may prime the tumor microenvironment for tumor growth even
though the diets are changed towards a regular diet. Future experiments could assess if
consumption of a high AGE diet may leave an epigenetic imprint on cells which may
promote tumor growth even upon diet change.
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As for aim 1, an alternative approach would be to observe a RAGE knockout
mouse model fed a regular or high AGE diet to observe if RAGE is required for the long
lasting and/or immediate effects, Cell signaling pathways are usually activated rapidly
upon ligand activation. Therefore, we anticipate that RAGE may be required for
immediate AGE mediated effects on tumor growth.

Specific Aim 3: To use whole genome analysis to identify the transcriptional
programs associated with dietary- AGE induced prostate cancer progression.
AGEs are known to activate multiple stress response pathways that can alter tumor cell
biology. AGE:RAGE signaling has been shown to lead to the activation of master
transcriptional regulators such as NFB, HIF1, and STAT3. The activation of these
transcription factors can lead to an increase in immune cell and oxidative stress
production to drive persistent inflammation which in turn can further increase AGE
production. We will use whole genome analysis to define the differentially expressed
genes in the tumors excised from mice fed a high AGE and regular diet. The goal of this
aim is to evaluate the molecular changes caused by chronic AGE consumption in
prostate tumors.

Task 1: Complete RNAseq Analysis
Task 2: Complete analysis of the RNAseq data
Task 3: Validate the RNAseq data at the mRNA level
Task 4: Validate the RNAseq data at the protein level
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Experimental Design
RNA Extraction. Tumor tissue was collected from the high AGE and regular fed MYCCaP mouse models from Specific Aim 1. RNA from the MYC-CaP tumors was extracted
using the Qiagen QIAshredder and RNAse Plus Mini Kits (Germany). Small samples
from each tumor were collected into 2mL microcentrifuge tube with 500uL of RIPA
buffer. Using a handheld homogenizer, the tumors were broken down into a lysate in
order to be used for the Qiagen kits. The QIA shredder column was utilized to remove
insoluble debris. The RNAse Plus Mini Kit uses an assortment of columns, tubes, and
centrifugation to remove genomic DNA and leave purified RNA. RNA quantification was
analyzed using the BioTek RNA microspot with a nucleic acid quantification program.
RNA must be flash frozen in liquid nitrogen and kept at -80°C until use.

RNAseq Analysis. Tumor tissue was collected from the high AGE and regular fed MYCCaP mouse models and RNA extracted. RNA sequencing (RNAseq) was performed on
each RNA sample by the Hollings Cancer Center (HCC) Genomics Core and the data
was analyzed by the MUSC Bioinformatics Core. The top differentially expressed genes
with associations with prostate cancer and AGE biology identified from the RNAseq
analysis were biologically validated at the RNA level using probe based real time PCR.
The qPCR was compared between regular diet and high AGE fed MYC-CaP tumor
samples. Differentially expressed genes validated by qPCR were biologically validated at
the protein level using IF staining. Biological pathways impacted by the differentially
expressed genes were examined using Pathway Assist.

Iscript PCR. Before preforming a Real Time PCR on the MYC-CaP tumor samples, the
RNA samples must go through reverse transcription to form cDNA. To each sample 4uL
of 5x Iscript reaction mix (Bio-Rad Laboratories Hercules, CA), 1uL Iscript Reverse
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Transcriptase (Bio-Rad Laboratories Hercules, CA), 1000ng of RNA from the MYC-CaP
tumor sample, and H20 to make final volume equivalent to 20uL were added a PCR
tube. Tubes were spun, assuring all samples were mixed properly, and inserted into the
Bio-Rad C1000 Touch Thermal Cycler for cDNA synthesis.
Real Time PCR. To begin the Real Time PCR, the cDNA samples were diluted 1/20 with
diH2O and the stock primers were diluted 1/5 with diH2O (Table 2). To prepare the Real
Time mix, we calculated the number of samples and mix needed for the wells being
used. All samples were run in triplicate and negative control was run in duplicate. All
primers were designed using the Universal Probe Library (UPL). For each gene being
tested, 5uL per well of 2x Super Mix (Bio-Rad Laboratories Hercules, CA), 0.1uL per well
of Roche Life Sciences forward primer, 0.1uL per well of the reverse primer, 0.1uL per
well Roche Life Sciences probe, 2.2uL per well H2O were added to a microcentrifuge
tube. Probes are lights sensitive, so the lights were off when they were in use. After
preparing the mix, flicked to mix and spun down. 7.5ul of the Real Time mix was added
to specified wells on the 96well PCR plate for that specific gene. MYC-CaP cDNA
samples were mixed, spun, and 2.5uL was added to respective wells. H2O was used in
place of cDNA as the negative control. A clear film was placed over the plate to seal in
the samples and the plate was lightly pulsed in plate spinner to ensure samples were at
the bottom. Real Time PCR was analyzed using the Roche Light Cycler 480 II.
Table 2: Real Time PCR Primers and Probes
Gene

Supplier

Forward Sequence

Reverse Sequence

Probe

MYC
MAD1
(MXD1)
RAGE
BanP
Ccr8

Roche
Roche

GCTTCGAAACTCTGGTGCAT
TGACAAAAGCCAAATTGCAT

CCGTTCTCCTTACTCTCACGA
CTGTCCATCCGAGTCCTCTC

63
19

Roche
Roche
Roche

TAGGTGCCCTCATCCTCGT
CTCTGGGAGGAGACACACTTG
AGAAGAAAGGCTCGCTCAGA

GGTCCACTGGATAAAGGATGG
AGCTGAGCACCCTGCAGTA
GGCTCCATCGTGTAATCCAT

1
40
4

F3
Trim16

Roche
Roche

TCCAGGAAAACTAACCAAAATAGC
GGTGAACACAGAGGCGACA

CCCACAATGATGAGTGTTTCTC
TCCAACTGCATACACCGAAG

38
94

Krt6a

Roche

ATCCAGCGGGTCAGGACT

GTCCAGGACCTTGTTCTGCT

32
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Western Blot. To analyze regular and high AGE tumors at the protein level we used
western blotting. To prepare samples, protein samples with 4% SDS dye for were boiled
for approximately 5 minutes in microcentrifuge tubes using clips to ensure lids stayed
closed. After boiling, the samples cooled to room temperature and were briefly spun so
that any unwanted debris was collected to the bottom of the tube. 1x Running Buffer was
prepared using BioRad10X Tris/Glycine/SDS Buffer. To set up the gel, the green tape
and comb were removed from the BioRad Mini-PROTEAN TGX Pre-cast gel, which was
then flushed with 1X Running buffer or H2O to ensure all wells were clear and straight.
The gel was loaded into the gasket, using a blank as needed depending on number of
gels being used. The gasket was filled with 1x Running Buffer up to appropriate line (2 or
4 gels) and checked for leaks. The gel was loaded with 10ul of protein ladder and 20ul of
samples to prospective wells. The lid was closed, matching electrodes on the gasket to
electrodes on the lid. The gel was run at 150V for approximately 45 minutes or until the
dye ran to the bottom of the gel. Transfer buffer was prepared and placed at 4° to cool.
When the gel finished, the proteins in the gel were transferred to a polyvinylidene
difluoride (PVDF) membrane. To transfer, the membrane was soaked in methanol to
hydrate for approximately 3 minutes. The hydrated membrane along with the sponges
and filter paper used for transferring were then soaked in 1X transfer buffer. The gel was
removed from its plastic casing and excess area of the gel was removed. The transfer
“Sandwich” was then assembled starting from the black side of the cassette; layered
sponge, filter paper, gel with the ladder on right, membrane, filter paper, sponge. Once
the sandwich was assembled, the cassette was closed and loaded into the chamber. An
ice pack was placed inside the chamber and filled with cold 1x transfer buffer. The lid
was closed, matching electrodes on the chamber to electrodes on the lid. Transfer was
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run at 100V for 1 hour. The membrane was then blocked for non-specific binding in 10%
Milk for 1 hour on an orbital shaker. Primary antibody was added in 5% milk to blot
overnight (Table 3). The primary antibody was removed by washing blot, 5 times for 5
minutes each in 1X TBST on an orbital shaker. Secondary antibody was added to the
blot on an orbital shaker for 1 hour then washed 5 times for 5 minutes each in 1X TBST.
To develop, 1mL of each BioRad Clarity Western ECL Substrate developing reagent (1:1
ratio) was mixed together and evenly added to the membrane for 5 minutes. The excess
reagent was removed and the membrane was placed in plastic wrap in a cassette
avoiding bubbles. In a dark room with the developer, film was removed from the box and
placed inside cassette for various intervals. Film was placed into developing machine to
process.
Table 3: MYC Western Blot Protocol
Ab
Supplier/Part #
Primary Ab Dilution/
Block/Incubation
Time
MYC
Cell Signaling
1hr block 10% Milk,
Technology
1:1000 MYC in 5% Milk
D84C12
overnight @ 4°C

Secondary Ab
Dilution/ Incubation
Time
1:2000 Anti-Rabbit
HRP in 5% Milk
1 hour @ RT

Results.
RNAseq data was validated for gene targets.
RNA sequencing analysis found 654 differentially expressed genes and 66
pathways that were impacted by the high AGE diet. Five genes were validated from the
RNAseq data at the mRNA level using probe based Real Time PCR. The differentially
expressed genes were chosen due to known associations with prostate cancer and AGE
biology. BanP, a tumor suppressor, and CCR8, involved in viral carcinogenesis, were
both significantly upregulated in the presence of a High AGE diet. Krt6a is involved in
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the morphogenesis of epithelium and was significantly down regulated in the presence of
a High AGE diet. F3 which is associated to the relationship between AGE-RAGE
signaling in Diabetes, was decreased with a High AGE diet. TRIM16 which has been
known to supress prostate cancer was found to be down regulated in the prescence of
increases AGEs (Figure 13).

Figure 13: Real Time PCR analysis of BanP, CCR8, KRT6A, F3, and TRIM16. BanP
and CCR8 were significantly upregulated in the presence of a High AGE diet while KRT6a,
F3, and TRIM16 are downregulated in the presence of a High AGE diet.

Consumptions of a high AGE diet significantly impacts energy metabolism
iPathway analysis identified that consumption of a high AGE diet impacted
multiple biological pathways associated with energy metabolism (Table 4).
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9.02E-19

3.15E-19

64

126

1.22E-18

1.05E-17

6.10E-18

75

171

2.32E-19

8.79E-17

7.55E-16

7.03E-16

53

103

3.53E-18

8.90E-16

7.65E-15

1.07E-14

47

88

2.48E-17

5.77E-15

4.96E-14

7.50E-14

46

88

4.44E-17

9.59E-15

8.24E-14

1.34E-13

46

89

1.92E-16

3.87E-14

3.33E-13

5.81E-13

47

95

1.09E-14

1.93E-12

1.66E-11

3.28E-11

45

96

1.41E-14

2.24E-12

1.93E-11

4.26E-11

44

93

1.56E-14

2.36E-12

2.03E-11

4.72E-11
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57

oxidative
phosphorylation
Selenoamino acid
metabolism
Metabolic pathways

3.19E-14

4.60E-12

3.95E-11

9.65E-11
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52

1.58E-12

1.60E-10

1.38E-09

4.77E-09

49

123

8.40E-10

7.06E-08

6.06E-07

2.54E-06

254

1272

Mitochondrial protein
import
Metabolism of proteins

3.35E-09

2.74E-07

2.36E-06

1.01E-05

28

62

5.90E-09

4.57E-07

3.93E-06

1.78E-05

308

1631

Organelle biogenesis
and maintenance
Mitochondrial Electron
Transport Chain

5.54E-08

3.99E-06

3.42E-05

1.67E-04

85

341

4.89E-07

3.02E-05

2.59E-04

1.48E-03

12

18

Name

pValue

FDR B&H

FDR B&Y

Bonferroni

Oxidative
phosphorylation
Respiratory electron
transport
The citric acid (TCA)
cycle and respiratory
electron transport
Respiratory electron
transport
Mitochondrial
translation termination
Mitochondrial
translation initiation
Mitochondrial
translation elongation
Mitochondrial
translation
Selenocysteine
synthesis
Peptide chain
elongation
Complex I biogenesis

6.24E-26

1.89E-22

1.62E-21

1.04E-22

1.05E-19

2.02E-21

Table 4: Biological pathways significantly affected by AGE consumption.

The top pathway that was impacted by a high AGE diet was oxidative
phosphorylation (Figure 14) which is a major source of ATP in tumor cells. Figure 15
also shows the differentially expressed genes which were impacted in prostate tumors
by AGE consumption. However, the high AGE diet also impacted multiple aspects
involving respiratory transport chain, nutrient metabolism and mitochondrial function.
Other pathways impacted by dietary AGE consumption included Alzheimer’s disease,
liver disease, ribosomal translation and cardiac muscle contraction (data not shown).
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Figure 14: Oxidative Phosphorylation pathway. RNA sequencing results of the genes and
specific areas affected by High AGE diet.

Figure 15: RNA sequencing results of genes impacted by a high AGE diet. Each of these
impacted genes are involved in Oxidative Phosphorylation.

MYC and MXD1 are impacted by high AGE consumption
The top differentially regulated gene impacted by the consumption of AGEs in the
prostate tumors was the MYC transcriptional repressor MXD1 (Mad1) the expression of
which was around 3-fold downregulated (Table 5). Validation at the level of mRNA
confirmed the downregulation of MXD1 (Figure 16).
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REG: REG: HIAGE: HIAGE:
Log2
Description 1040 1041 1043 1048 baseMean FoldChange pvalue
MAX
AW122478| dimerization
Mxd1 17119 Mad|Mad1 protein 1 2824 3610 986
899 1985.45077 -1.3615475 6.49E-17

Symbol

Gene
ID

Alias

Table 5: MXD1 was the top gene for RNA Sequencing results for differentially
expressed genes.

We also assessed the levels of MYC and AGE receptor RAGE in the tumors
excised from the mice fed the high AGE and regular diets. At the level of mRNA, we saw
a downregulation of MYC and no significant change in RAGE (Figure 16).

Figure 16: Real Time PCR analysis of RAGE, MYC, and MXD1. When RAGE is upregulated,
MYC and MXD1 are downregulated.

However, at the level of protein (Western blot) both RAGE and MYC

expression was elevated in the tumors from the high AGE fed mice compared to
the regular fed (Figure 17).
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Figure 17: RAGE and MYC expression in Western
Blot. At protein level, high AGE tumor protein samples
expressed higher levels of RAGE and MYC.

Discussion and Alternative Approaches.
The RNA sequencing analysis found 654 differentially expressed genes and 66
pathways that were impacted by the high AGE diet. The differentially expressed genes
that were chosen for Real Time PCR analysis had known associations with prostate
cancer and AGE biology. BanP, a tumor suppressor, and CCR8, involved in viral
carcinogenesis, were both significantly upregulated in the presence of a High AGE diet.
BanP, BTG3 associated nuclear protein, is also known as scaffold/matrix attachment
region binding protein (SMAR1). BanP causes chromatin remodeling which leads the
suppression of transcription42. CCR8, chemokine C-C motif receptor 8, is expressed in T
helper 2 cells and suppresses activation of macrophages43. Krt6a, keratin 6a, is a
kertinocyte which will migrate to the site of injury to promote wound healing, is involved
in the morphogenesis of epithelium, and was significantly down regulated in the
presence of a High AGE diet44. F3, coagulation factor III, is associated to the relationship
between AGE-RAGE signaling in Diabetes. F3 is also involved in clot formation, has
downstream effects on expression of pro-inflammatory cytokines, and was decreased
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with a High AGE diet45. TRIM16, tripartite motif-containing 16, recognizes damaged
endomembranes and recruits autophagosomes, has been known to supress prostate
cancer, and was found to be down regulated in the prescence of increases AGEs46. A
high AGE diet leads to increased chromatin remodeling and deactivation of
macrophages while decreasing epithelialization and autophagosome recruitment which
may lead to an ideal tumor environment.
Our data indicates that at the level of message as RAGE levels increased within
tumor tissue, MYC and MAD1 decreased. While MYC RNA expression was down
regulated in the presence of the high AGE diet, our studies show that it was increased at
the protein level in response to the high AGE diet. This leads us to believe that the
change is not happening at a transcriptional level but dietary AGEs may result in MYC
protein stabilization to increase the half-life. Future studies can compare MYC protein
half-life in response to AGE. Other studies have shown that MYC may function
specifically under a specific threshold where it can become tumorigenic when
overexpressed but reach a point of inactivation. This may not happen in all tumors but
during MYC inactivation, tumors undergo proliferative arrest, differentiation, and
apoptosis. Once MYC reaches inactivation, there is a shift in transcription which
promotes arrest rather than proliferation47. AGEs may inhibit MYC inactivation by
decreasing the levels of MAD1 which is a transcriptional repressor of MYC.
MYC is a master regulator of genes involved in energy metabolism which were
key pathways impacted by the high AGE diet. Increased energy metabolism is one of the
hallmarks of cancer as it provides the fuel and nutrients for uncontrolled neoplastic
growth. This may represent a key mechanism by which dietary AGEs confers increased
tumor growth. The Seahorse Bioanalyzer directly measures the oxygen consumption
rate (OCR) and extracellular acidification rate (ECAR) of live cells to assess energy
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associated pathways. Future studies are planned to analyze the effects of AGEs on
including mitochondrial respiration and glycolysis.
Significance of Study
Through today’s “Western” lifestyle of sedentary habits and increased
consumption of cheap processed foods, AGEs are something to look out for. Our studies
have shown how a high AGE diet can affect the development of prostate tumors and
cause a threefold increase. By choosing a healthier lifestyle, tumor growth can be vastly
decreased.
Little is known about the effects of AGEs on the cancer phenotype. The proposed
studies established that dietary AGEs promote prostate tumor growth. For the first time,
these studies have provided a mechanistic link between dietary AGEs and in vivo
prostate tumor growth. These studies have allowed insight into the effects of the modern
diet on tumor growth as well as assess the molecular implications caused by chronic
AGE consumption on tumor biology. Defining the cancer associated biological pathways
that are affected by an unhealthy diet may allow new avenues for lifestyle and
therapeutic intervention.
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